A groundbreaking shift in our drug policy has happened, as the regulators allow the legalization of psilocybin mushrooms for therapeutic purposes. Before this, these substances were severely restricted, but a increasing body of evidence suggests they potentially offer aid for mental health conditions like anxiety. This development represents a key